(Q36987747)

17 August 2017

1 reference

23 September 2020

Intraperitoneal therapy in the management of ovarian carcinoma (English)

1 reference

antineoplastic combined chemotherapy protocols

17 August 2017

1 reference

23 September 2020

1 reference

14 September 2020

1 reference

23 September 2020

1 reference

Markman M

1

1 reference

17 August 2017

Hakes T

2

1 reference

17 August 2017

Reichman B

3

1 reference

17 August 2017

Hoskins W

4

1 reference

17 August 2017

Rubin S

5

1 reference

17 August 2017

Jones W

6

1 reference

17 August 2017

Almadones L

7

1 reference

17 August 2017

Lewis JL Jr

8

1 reference

17 August 2017

1 July 1989

1 reference

Yale Journal of Biology and Medicine

17 August 2017

8 references

17 August 2017

13 March 2019

14 March 2019

24 March 2019

3 April 2019

25 June 2019

14 September 2020

23 September 2020

62

1 reference

17 August 2017

4

1 reference

17 August 2017

393-403

1 reference

Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Pharmacokinetics of Ip cisplatin in refractory ovarian carcinoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Pharmacologic data and technical feasibility of intraperitoneal doxorubicin administration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Infectious peritonitis in patients receiving intraperitoneal chemotherapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Mitoxantrone: a new anticancer drug with significant clinical activity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Intraperitoneal mitomycin C in the treatment of peritoneal carcinomatosis following second-look surgery

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Phase II trial of mitomycin C plus 5-FU in the treatment of drug-refractory ovarian cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Second trial drugs in ovarian cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Intracavitary administration of biological agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

The effect of volume on the distribution of substances instilled into the peritoneal cavity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Pharmacologic reversal of drug resistance in ovarian cancer.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Experimental and clinical results with intraperitoneal cisplatin.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Intraperitoneal cis-platinum as salvage therapy for refractory epithelial ovarian cancer.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Kinetic characterization and response to chemotherapy in a transplantable murine ovarian cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Chemotherapy for murine ovarian cancer: a rationale for ip therapy with adriamycin

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Prolonged Disease-Free Survival in Hodgkin's Disease with MOPP Reinduction After First Relapse

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Penetration and binding of vinblastine and 5-fluorouracil in cellular spheroids.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2589079

Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity

4 September 2018

1 reference

12 December 2020

Treatment strategies for "high-risk" leukemia

1 reference

12 December 2020

Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer

1 reference

12 December 2020

Intraperitoneal cytosine arabinoside therapy in ovarian carcinoma

1 reference

12 December 2020

Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro

1 reference

12 December 2020

Small-Cell Carcinoma of Lung: Reinduction Therapy After Late Relapse

1 reference

12 December 2020

Recurrent ovarian carcinoma: retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent

1 reference

12 December 2020

Phase I study and pharmacokinetics of intraperitoneal carboplatin

1 reference

12 December 2020

Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy

1 reference

12 December 2020

Clinical pharmacology of intraperitoneal cisplatin

1 reference

12 December 2020

Phase II study of mitoxantrone in epithelial ovarian cancer

1 reference

12 December 2020

Totally implantable system for peritoneal access

1 reference

12 December 2020

Intraperitoneal infusion of doxorubicin in the treatment of gynecologic carcinomas

1 reference

12 December 2020

Use of nitrogen mustard in treatment of serous effusions of neoplastic origin

1 reference

12 December 2020

Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma

1 reference

12 December 2020

Catheter complications associated with intraperitoneal chemotherapy

1 reference

12 December 2020

Pharmacology of intraperitoneal infusion 5-fluorouracil and mitomycin-C

1 reference

12 December 2020

Epithelial carcinoma of the ovary: current strategies

1 reference

12 December 2020

Intraperitoneal chemotherapy with melphalan

1 reference

12 December 2020

Intraperitoneal chemotherapy with melphalan plus glutaminase

1 reference

12 December 2020

Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route

1 reference

12 December 2020

Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally

1 reference

12 December 2020

Phase II study of low-dose mitomycin in patients with ovarian cancer previously treated with chemotherapy

1 reference

12 December 2020

Hemisulfur mustard in the palliation of patients with metastatic ovarian carcinoma

1 reference

12 December 2020

Intraperitoneal cisplatin with systemic thiosulfate protection

1 reference

12 December 2020

The route of absorption of intraperitoneally administered compounds

1 reference

12 December 2020

Phase II trial of 5-FU administered Ip to patients with refractory ovarian cancer

1 reference

12 December 2020

Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide

1 reference

12 December 2020

Intraperitoneal Chemotherapy With Cisplatin and Melphalan

1 reference

12 December 2020

Identifiers

1 reference

17 August 2017

PubMed publication ID

2688324

1 reference